ViƱa, Analyn T.

HRN: 21-41-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2022
METRONIDAZOLE 500MG (TAB)
05/31/2022
06/07/2022
IVT
500mg/tab
TID
Post NSVD; Thickly MSAF
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: